Souhaitez-vous accéder aux communiqués récents ?

Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure

GATINEAU, Québec, 14 avr. 2026 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens, en partenariat avec la Société canadienne de la douleur, a...

GATINEAU, Quebec, April 14, 2026 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans, in partnership with the Canadian Pain Society, hosted a first-of-its-kind national...

Judge gives nod to the admissibility of plaintiffs' expert testimony supporting general causation in J&J talc MDL.

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced that the...

LONDON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- With office parties, cocktails with friends and end-of-year celebrations in full swing, many of us brace for hangovers without realising that festive...

LONDON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Today, global leaders, survivor advocates, policymakers, and experts will gather at the Design Museum in London to launch ALL IN: Global Leaders for Ending...

Exclusive cycle tracking data reveals 280 million days of bleeding were tracked across the globe in the last 12 monthsApp users logged 34 million sex sessions and 4.4 million orgasms across 202544.6...

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in family building solutions, today announced new men’s health research exploring experiences and views on...

LONDON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clue, the #1 women-led period and cycle tracker trusted by over 100 million worldwide, has today announced expanded integrations with leading wearable...